BioNTech SE (BNTX) Operating Leases (2018 - 2025)
Historic Operating Leases for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $242.0 million.
- BioNTech SE's Operating Leases changed N/A to $242.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $242.0 million, marking a year-over-year change of. This contributed to the annual value of $271.6 million for FY2024, which is 1650.43% up from last year.
- According to the latest figures from Q3 2025, BioNTech SE's Operating Leases is $242.0 million.
- In the past 5 years, BioNTech SE's Operating Leases registered a high of $14.3 billion during Q1 2022, and its lowest value of $207.7 million during Q4 2021.
- Its 5-year average for Operating Leases is $4.4 billion, with a median of $271.6 million in 2024.
- Per our database at Business Quant, BioNTech SE's Operating Leases surged by 39501.71% in 2022 and then tumbled by 9676.68% in 2024.
- Quarter analysis of 5 years shows BioNTech SE's Operating Leases stood at $207.7 million in 2021, then increased by 3.18% to $214.4 million in 2022, then grew by 8.77% to $233.2 million in 2023, then grew by 16.5% to $271.6 million in 2024, then decreased by 10.91% to $242.0 million in 2025.
- Its Operating Leases was $242.0 million in Q3 2025, compared to $260.5 million in Q2 2025 and $259.6 million in Q1 2025.